Why the study?
Does permanent cardiac pacing prevent syncope in patients with frequent vasovagal syncope?
Does permanent cardiac pacing prevent syncope in patients with frequent vasovagal syncope?
Permanent cardiac pacing may offer substantial improvement over medical therapy for preventing vasovagal syncope, though definitive evidence from randomized trials is pending.
Answers are grounded in this paper and cite their sources.
May support pacing in refractory vasovagal syncope; leaves open efficacy confirmation in randomized trials.
Patients with frequent vasovagal syncope have a poor quality of life and often resist treatment with standard pharmacologic approaches. Although the evidence is weak, clinical vasovagal syncope is probably associated with some degree of bradycardia. Studies of temporary pacing during tilt table tests showed that pacing prevented syncope in a little over half of patients who developed a vasovagal response. Six open-label studies of permanent pacing show that permanent pacemaker therapy is associated with substantial improvement over medical therapy. The roles of specific pacemaker modes have not been determined, although there is some evidence that rate-drop responsiveness helps. The second Vasovagal Pacemaker Study will quantify the true benefits of pacing for vasovagal syncope and assess the role of rate-drop response algorithms.
No takes yet. Share an insight, caveat, or question.
Raj et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: